Revance Therapeutics, Inc. ( RVNC) - Stock Earnings
Stock symbol RVNC is outdated, potentially delisted? Maybe it is available on other exchange?
RVNC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -53.2 million USD | 51.9 million USD |
| 2024Q2 | -37.5 million USD | 65.4 million USD |
| 2024Q3 | -35.1 million USD | 58.8 million USD |
RVNC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -286.8 million USD | 77.8 million USD |
| 2022 | -356.4 million USD | 132.6 million USD |
| 2023 | -324.0 million USD | 234.0 million USD |
RVNC
Price: $3.65
52 week price:
Earnings Per Share: -3.34 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 728800
Ebitda: -30.2 millionMarket Capitalization: 381.0 million